Expectant management as an option for men with stage T1c prostate cancer: a preliminary study
- PMID: 9436286
- DOI: 10.1007/BF01300184
Expectant management as an option for men with stage T1c prostate cancer: a preliminary study
Abstract
The outcome of patients selecting observation of clinical stage T1c prostate cancer is unknown. A total of 101 men with clinical stage T1c prostate cancer were evaluated, counseled, and monitored in a standard fashion. Altogether, 27 men who elected observation were older and had greater co-morbidity but similar tumor characteristics as compared with 74 men who elected radical prostatectomy. In all, 9 men demonstrated clinical or biochemical evidence of progression after a mean follow-up of 23 months; 4 men who underwent radical prostatectomy had specimen-confined disease and undetectable post-operative levels of PSA. Observation appears to be a viable option for some men with clinical stage T1c prostate cancer.
Similar articles
-
Radical prostatectomy as treatment for prostate-specific antigen-detected stage T1c prostate cancer.World J Urol. 1997;15(6):373-7. doi: 10.1007/BF01300186. World J Urol. 1997. PMID: 9436288
-
Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.J Urol. 2003 Jun;169(6):2129-35. doi: 10.1097/01.ju.0000065763.21602.14. J Urol. 2003. PMID: 12771734
-
Prospective evaluation of men with stage T1C adenocarcinoma of the prostate.J Urol. 1997 Jun;157(6):2206-9. J Urol. 1997. PMID: 9146616 Free PMC article. Review.
-
Are prostate carcinoma clinical stages T1c and T2 similar?Int Braz J Urol. 2006 Mar-Apr;32(2):165-71. doi: 10.1590/s1677-55382006000200006. Int Braz J Urol. 2006. PMID: 16650293
-
Expectant management of stage A-1 (T1a) prostate cancer utilizing serum PSA levels: a preliminary report.J Surg Oncol. 1999 Jan;70(1):49-53. doi: 10.1002/(sici)1096-9098(199901)70:1<49::aid-jso9>3.0.co;2-x. J Surg Oncol. 1999. PMID: 9989421 Review.
Cited by
-
Watchful waiting versus active surveillance: appropriate patient selection.Curr Urol Rep. 2008 May;9(3):211-6. doi: 10.1007/s11934-008-0037-9. Curr Urol Rep. 2008. PMID: 18765115 Review.
-
Treatment outcomes of radical prostatectomy in potential candidates for 3 published active surveillance protocols.Urology. 2010 Feb;75(2):414-8. doi: 10.1016/j.urology.2009.07.1353. Epub 2009 Dec 5. Urology. 2010. PMID: 19963249 Free PMC article.
-
[Active surveillance for prostate cancer].Urologe A. 2008 Mar;47(3):261-9. doi: 10.1007/s00120-008-1638-0. Urologe A. 2008. PMID: 18273597 Review. German.
-
Prostate cancer: a comprehensive review.Med Oncol. 2000 May;17(2):85-105. doi: 10.1007/BF02796203. Med Oncol. 2000. PMID: 10871814 Review. No abstract available.
-
Continuing controversy over monitoring men with localized prostate cancer: a systematic review of programs in the prostate specific antigen era.J Urol. 2006 Aug;176(2):439-49. doi: 10.1016/j.juro.2006.03.030. J Urol. 2006. PMID: 16813862 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous